The UCSF Helen Diller Family Comprehensive Cancer Center announced today that the UCSF Prostate Cancer Program is the recipient of the National Cancer Institute’s (NCI) Specialized Programs of ...
Study shows how a cell-signaling receptor helps prostate cancer cells accumulate cholesterol, a process linked to tumor growth and treatment resistance. Texas A&M University Researchers at Texas A&M ...
The largest real-world study ever conducted on prostate cancer in Brazil analyzed data from 670,205 patients treated through ...
Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows
A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer Institute and professor of internal medicine at the University of Utah (the U), has ...
According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime. In addition, about 1 in 44 men will die from the disease, ...
Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy. When blocked, these enzymes cause the androgen receptor to collapse, ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...
Columbia University scientists say they have homed in on a gene that appears to drive one of the deadliest forms of prostate cancer, and shutting it down in mice made stubborn tumors shrink. The work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results